Astrana Health [ASTH] vs Ardent Health [ARDT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Astrana Health wins in 4 metrics, Ardent Health wins in 14 metrics, with 0 ties. Ardent Health appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAstrana HealthArdent HealthBetter
P/E Ratio (TTM)55.297.42Ardent Health
Price-to-Book Ratio1.851.60Ardent Health
Debt-to-Equity Ratio83.20138.17Astrana Health
PEG Ratio-1.050.10Astrana Health
EV/EBITDA13.247.08Ardent Health
Profit Margin (TTM)1.04%4.11%Ardent Health
Operating Margin (TTM)3.11%8.34%Ardent Health
EBITDA Margin (TTM)3.11%8.34%Ardent Health
Return on Equity5.44%24.32%Ardent Health
Return on Assets (TTM)3.25%5.61%Ardent Health
Free Cash Flow (TTM)$44.17M$127.52MArdent Health
1-Year Return-48.66%-23.97%Ardent Health
Price-to-Sales Ratio (TTM)0.550.32Ardent Health
Enterprise Value$1.31B$4.12BArdent Health
EV/Revenue Ratio0.540.67Astrana Health
Gross Profit Margin (TTM)11.91%83.55%Ardent Health
Revenue per Share (TTM)$50$44Astrana Health
Earnings per Share (Diluted)$0.52$1.89Ardent Health
Beta (Stock Volatility)0.81N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Astrana Health vs Ardent Health Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Astrana Health0.42%-0.38%-2.17%19.54%-1.43%-10.34%
Ardent Health2.71%8.52%6.67%8.27%19.40%-14.54%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Astrana Health-48.66%-8.35%57.93%340.76%466.08%466.08%
Ardent Health-23.97%-16.59%-16.59%-16.59%-16.59%-16.59%

News Based Sentiment: Astrana Health vs Ardent Health

Astrana Health

News based Sentiment: POSITIVE

Astrana Health reported strong financial performance with significant revenue and EPS growth, coupled with a very positive analyst outlook and a substantial potential upside. This combination of factors makes it a noteworthy development for investors.

View Astrana Health News Sentiment Analysis

Ardent Health

News based Sentiment: MIXED

Ardent Health experienced a slight stock decline in October, but also showed significant improvement in its Return on Capital Employed (ROCE) and appointed a new COO. These mixed signals create a balanced investment narrative, suggesting both potential and risk.

View Ardent Health News Sentiment Analysis

Performance & Financial Health Analysis: Astrana Health vs Ardent Health

MetricASTHARDT
Market Information
Market Cap i$1.39B$2.01B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i324,610336,040
90 Day Avg. Volume i348,273381,800
Last Close$28.87$14.40
52 Week Range$21.20 - $63.20$10.10 - $20.72
% from 52W High-54.32%-30.50%
All-Time High$133.23 (Nov 15, 2021)$20.72 (Oct 14, 2024)
% from All-Time High-78.33%-30.50%
Growth Metrics
Quarterly Revenue Growth0.35%0.12%
Quarterly Earnings Growth-0.51%0.71%
Financial Health
Profit Margin (TTM) i0.01%0.04%
Operating Margin (TTM) i0.03%0.08%
Return on Equity (TTM) i0.05%0.24%
Debt to Equity (MRQ) i83.20138.17
Cash & Liquidity
Book Value per Share (MRQ)$15.58$8.77
Cash per Share (MRQ)$6.85$3.83
Operating Cash Flow (TTM) i$130.56M$301.98M
Levered Free Cash Flow (TTM) i$97.63M$19.78M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Astrana Health vs Ardent Health

MetricASTHARDT
Price Ratios
P/E Ratio (TTM) i55.297.42
Forward P/E i18.797.01
PEG Ratio i-1.050.10
Price to Sales (TTM) i0.550.32
Price to Book (MRQ) i1.851.60
Market Capitalization
Market Capitalization i$1.39B$2.01B
Enterprise Value i$1.31B$4.12B
Enterprise Value Metrics
Enterprise to Revenue i0.540.67
Enterprise to EBITDA i13.247.08
Risk & Other Metrics
Beta i0.81N/A
Book Value per Share (MRQ) i$15.58$8.77

Financial Statements Comparison: Astrana Health vs Ardent Health

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ASTHARDT
Revenue/Sales i$654.81M$1.50B
Cost of Goods Sold i$576.84M$258.86M
Gross Profit i$77.97M$1.24B
Research & Development iN/AN/A
Operating Income (EBIT) i$20.34M$67.09M
EBITDA i$31.10M$124.58M
Pre-Tax Income i$16.83M$74.20M
Income Tax i$6.61M$15.23M
Net Income (Profit) i$10.22M$58.97M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ASTHARDT
Cash & Equivalents i$258.52M$495.04M
Total Current Assets i$613.27M$1.76B
Total Current Liabilities i$361.27M$830.14M
Long-Term Debt i$433.40M$2.26B
Total Shareholders Equity i$517.71M$1.56B
Retained Earnings i$292.88M$407.18M
Property, Plant & Equipment i$47.55M$2.06B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ASTHARDT
Operating Cash Flow i$12.67M$21.34M
Capital Expenditures i$-3.07M$-22.91M
Free Cash Flow i$13.56M$-47.70M
Debt Repayment i$-428.38M$-1.39M
Common Stock Repurchase i$-1.32MN/A

Short Interest & Institutional Ownership Analysis

MetricASTHARDT
Shares Short i1.55M2.04M
Short Ratio i4.497.09
Short % of Float i0.06%0.06%
Average Daily Volume (10 Day) i324,610336,040
Average Daily Volume (90 Day) i348,273381,800
Shares Outstanding i47.93M142.75M
Float Shares i37.56M33.80M
% Held by Insiders i0.22%0.23%
% Held by Institutions i0.53%0.74%

Dividend Analysis & Yield Comparison: Astrana Health vs Ardent Health

MetricASTHARDT
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A